Astera Labs, Inc. $ALAB Holdings Reduced by Driehaus Capital Management LLC

Key Points

• Driehaus Capital Management LLC reduced its stake in Astera Labs, Inc. by 84.8%, selling 1,123,045 shares and retaining approximately 201,285 shares valued at $12,011,000.
• In the first quarter, several institutional investors, including Sound Income Strategies LLC and Hazlett Burt & Watson Inc., significantly increased their holdings in Astera Labs.
• Astera Labs reported strong financial results, with revenue increasing by 149.5% compared to the previous year, and is forecasting a Q3 2025 EPS guidance of 0.380-0.390.

Driehaus Capital Management LLC decreased its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 84.8% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 201,285 shares of the company's stock after selling 1,123,045 shares during the quarter. Driehaus Capital Management LLC owned about 0.12% of Astera Labs worth $12,011,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in ALAB. Vanguard Group Inc. raised its holdings in Astera Labs by 0.9% in the 1st quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company's stock valued at $554,780,000 after buying an additional 85,846 shares during the period. Bank of Nova Scotia increased its position in Astera Labs by 3,742.2% during the first quarter. Bank of Nova Scotia now owns 964,400 shares of the company's stock worth $57,546,000 after buying an additional 939,300 shares during the period. Polar Capital Holdings Plc purchased a new position in Astera Labs during the 4th quarter worth $126,812,000. BNP Paribas Financial Markets lifted its position in Astera Labs by 4,172.8% during the 4th quarter. BNP Paribas Financial Markets now owns 816,619 shares of the company's stock worth $108,161,000 after acquiring an additional 797,507 shares during the period. Finally, Fuller & Thaler Asset Management Inc. boosted its holdings in shares of Astera Labs by 25.2% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 636,536 shares of the company's stock valued at $37,982,000 after acquiring an additional 128,163 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.

Analyst Upgrades and Downgrades

ALAB has been the subject of a number of research reports. Needham & Company LLC lifted their target price on shares of Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Zacks Research upgraded shares of Astera Labs to a "strong-buy" rating in a report on Tuesday, August 12th. Evercore ISI lifted their target price on shares of Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 6th. Wall Street Zen raised Astera Labs from a "hold" rating to a "buy" rating in a research note on Saturday, August 16th. Finally, Susquehanna upped their target price on Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research note on Thursday, August 7th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $135.75.

Insiders Place Their Bets

In other news, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the sale, the chief operating officer owned 5,525,545 shares in the company, valued at $939,453,160.90. This trade represents a 4.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Michael Truett Tate sold 100,000 shares of the business's stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $171.38, for a total transaction of $17,138,000.00. Following the completion of the transaction, the chief financial officer owned 518,996 shares in the company, valued at $88,945,534.48. This represents a 16.16% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,728,116 shares of company stock worth $239,272,181 in the last 90 days. 12.50% of the stock is owned by company insiders.

Astera Labs Trading Down 3.7%

Shares of Astera Labs stock traded down $6.95 during trading hours on Friday, reaching $182.20. The stock had a trading volume of 3,744,678 shares, compared to its average volume of 5,673,605. The firm has a market capitalization of $30.29 billion, a price-to-earnings ratio of 325.36, a P/E/G ratio of 4.62 and a beta of 1.46. Astera Labs, Inc. has a 1 year low of $36.85 and a 1 year high of $199.47. The firm has a 50 day simple moving average of $132.43 and a two-hundred day simple moving average of $95.76.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. During the same quarter in the prior year, the business earned $0.13 earnings per share. The business's quarterly revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Sell-side analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.